RIGEL PHARMACEUTICALS INC financial data

Symbol
RIGL on Nasdaq
Location
South San Francisco, CA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 224% % 30%
Quick Ratio 12% % 13%
Debt-to-equity 87% %
Return On Equity 241% %
Return On Assets 129% % 929%
Operating Margin 43% % 216%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,473,130 shares 3.4%
Common Stock, Shares, Outstanding 18,310,934 shares 3.4%
Entity Public Float $331,600,000 USD 132%
Common Stock, Value, Issued $18,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 17,987,000 shares 2.3%
Weighted Average Number of Shares Outstanding, Diluted 18,840,000 shares 6.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $294,282,000 USD 64%
Costs and Expenses $168,816,000 USD 8.9%
Operating Income (Loss) $125,466,000 USD 419%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $121,827,000 USD 563%
Income Tax Expense (Benefit) $245,197,000 USD -27932%
Net Income (Loss) Attributable to Parent $367,024,000 USD 1999%
Earnings Per Share, Basic 20.4 USD/shares 1961%
Earnings Per Share, Diluted 19.48 USD/shares 1868%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $40,580,000 USD -28%
Cash, Cash Equivalents, and Short-term Investments $155,012,000 USD 100%
Accounts Receivable, after Allowance for Credit Loss, Current $51,763,000 USD 24%
Inventory, Net $11,506,000 USD 92%
Other Assets, Current $5,207,000 USD 15%
Assets, Current $240,166,000 USD 78%
Deferred Income Tax Assets, Net $245,852,000 USD
Property, Plant and Equipment, Net $30,000 USD -67%
Operating Lease, Right-of-Use Asset $920,000 USD 274%
Other Assets, Noncurrent $1,908,000 USD 25%
Assets $513,594,000 USD 213%
Accounts Payable, Current $7,191,000 USD 115%
Employee-related Liabilities, Current $11,914,000 USD 18%
Contract with Customer, Liability, Current $1,355,000 USD 0%
Liabilities, Current $99,237,000 USD 57%
Operating Lease, Liability, Noncurrent $395,000 USD
Other Liabilities, Noncurrent $0 USD -100%
Liabilities $122,114,000 USD -24%
Accumulated Other Comprehensive Income (Loss), Net of Tax $181,000 USD 1710%
Retained Earnings (Accumulated Deficit) $1,023,041,000 USD 26%
Stockholders' Equity Attributable to Parent $391,480,000 USD 11806%
Liabilities and Equity $513,594,000 USD 213%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $893,000 USD 82%
Net Cash Provided by (Used in) Financing Activities $484,000 USD
Net Cash Provided by (Used in) Investing Activities $10,552,000 USD -3471%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 18,310,934 shares 3.4%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $40,637,000 USD -28%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,653,000 USD -1.8%
Deferred Tax Assets, Valuation Allowance $46,698,000 USD -86%
Deferred Tax Assets, Gross $292,550,000 USD -11%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $367,195,000 USD 2000%
Lessee, Operating Lease, Liability, to be Paid $1,101,000 USD
Property, Plant and Equipment, Gross $347,000 USD -1.7%
Operating Lease, Liability, Current $614,000 USD 115%
Lessee, Operating Lease, Liability, to be Paid, Year Two $409,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $692,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $216,008,000 USD -3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $9,050,000 USD 3.1%
Operating Lease, Payments $16,000 USD -98%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,400,000 USD 14%
Depreciation, Depletion and Amortization $604,000 USD 51%
Deferred Tax Assets, Net of Valuation Allowance $245,852,000 USD
Share-based Payment Arrangement, Expense $12,711,000 USD 2.6%
Interest Expense $7,576,000 USD -3.7%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%